What is the average price of sertraline exports from India?

The average unit price for sertraline exports from India is $2.15 USD per unit, with prices ranging from $0.00 to $600.00 depending on formulation, packaging, and order volume. The total market is valued at $560.5M across 5,183 shipments.

Which ports handle sertraline exports from India?

The primary ports for sertraline exports from India are SAHAR AIR CARGO ACC (INBOM4) (11.4% of shipments), SAHAR AIR (9.6% of shipments), NHAVA SHEVA SEA (INNSA1) (7.4% of shipments), DHANNAD ICD (5.2% of shipments), HYDERABAD ICD (3.6% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Why is India a leading exporter of sertraline?

India is one of the world's leading exporters of sertraline due to its large base of 218 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports sertraline to 88 countries, demonstrating 45% global market coverage.

What certifications do Indian sertraline exporters need?

Indian sertraline exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

How many buyers import sertraline from India?

There are 553 registered buyers importing sertraline from India, spread across 88 countries. The repeat buyer rate is 67.3%, indicating strong long-term trade relationships and consistent product quality.

What is the market share of the top sertraline supplier from India?

CIPLA LIMITED is the leading sertraline exporter from India with a market share of 55.5% and total export value of $311.1M across 550 shipments. The top 5 suppliers together control 88.8% of total export value.

Sertraline

India Pharmaceutical Trade Intelligence

$560.5M218 Suppliers88 CountriesHS 30049099

ExportsIndia → UNITED STATES60.3%India → BELGIUM10.4%

ImportsUNITED STATES → India$192.5K GERMANY → India$14.4K

#1 Supplier: CIPLA LIMITED #1 Buyer: CIPLA USA

Sertraline Export Data from India (2026) — Suppliers, Buyers & Trade Stats | TransData Nexus | TransData Nexus

How India Exports Sertraline to the World

Q: Who are the top sertraline exporters from India?

The top sertraline exporters from India are: 1. CIPLA LIMITED — $311.1M (55.5% market share); 2. AUROBINDO PHARMA LTD — $76.5M (13.6% market share); 3. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $67.8M (12.1% market share); 4. LUPIN LIMITED — $29.5M (5.3% market share); 5. APL HEALTHCARE LIMITED — $13.0M (2.3% market share). Together they account for 88.8% of India's total sertraline export value.

Q: What is the total export value of sertraline from India?

The total export value of sertraline from India is $560.5M USD, recorded across 5,183 shipment transactions from 218 active exporters to 88 destination countries. The average shipment value is $108.1K.

Q: Which countries import sertraline from India?

India exports sertraline to 88 countries worldwide. The top importing countries are: UNITED STATES (60.3% share, $338.0M), BELGIUM (10.4% share, $58.2M), MALTA (6.4% share, $35.6M), FINLAND (4.6% share, $25.9M), JAPAN (4.5% share, $25.0M). These five markets account for 86.1% of total export value.

Q: What is the HS code for sertraline exports from India?

The primary HS code for sertraline exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Between 2022 and 2026, India exported $560.5M worth of sertraline across 5,183 verified shipments to 88 countries — covering 45% of world markets in the CNS & Psychiatric segment. The largest destination is UNITED STATES (60.3%). CIPLA LIMITED leads with a 55.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049099

Sertraline export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Sertraline export data snapshot — $560.5M · 218 exporters · 88 countriesTransData Nexus · Indian Customs Data

Top Sertraline Exporters from India

218 active exporters · Ranked by export value

View all 218 →

Top Sertraline Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	CIPLA LIMITED	$311.1M	550	2	55.5%
2	AUROBINDO PHARMA LTD

Top Countries Importing Sertraline from India

88 destination markets · Ranked by import value

All 88 countries →

Top Countries Importing Sertraline from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$338.0M	60.3%
2	BELGIUM	$58.2M	10.4%
3	MALTA	$35.6M	6.4%
4	FINLAND	$25.9M	4.6%
5	JAPAN	$25.0M	4.5%
6	UNITED KINGDOM	$12.8M	2.3%
7	RUSSIA	$10.6M	1.9%
8	CANADA	$9.9M	1.8%
9	BRAZIL	$9.0M	1.6%
10	AUSTRALIA	$8.2M	1.5%

UNITED STATES is India's largest sertraline export destination, absorbing 60.3% of total exports worth $338.0M. The top 5 importing countries — UNITED STATES, BELGIUM, MALTA, FINLAND, JAPAN — together account for 86.1% of India's total sertraline export value. The remaining 83 destination countries collectively receive the other 13.9%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Sertraline to India?

12 origin countries · Total import value: $224.9K

India imports sertraline from 12 countries with a combined import value of $224.9K. The largest supplier is UNITED STATES ($192.5K, 109 shipments), followed by GERMANY and UNITED KINGDOM. All values are from Indian Customs (DGFT) import records.

Countries Supplying Sertraline to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$192.5K	109	85.6%
2	GERMANY	$14.4K	8	6.4%
3	UNITED KINGDOM	$5.9K	6	2.6%
4	GREECE	$5.4K	9	2.4%
5	CANADA	$1.9K	31	0.8%
6	SPAIN	$1.4K	16	0.6%
7	MALTA	$1.2K	8	0.5%
8	NETHERLANDS	$1.2K	1	0.5%
9	BRAZIL	$905	2	0.4%
10	CHINA	$49	1	0.0%

Showing top 10 of 12 origin countries

UNITED STATES is the largest supplier of sertraline to India, accounting for 85.6% of total import value. The top 5 origin countries — UNITED STATES, GERMANY, UNITED KINGDOM, GREECE, CANADA — together supply 97.9% of India's sertraline imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Sertraline

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, sertraline is approved for the treatment of major depressive disorder, obsessive-compulsive disorder, panic disorder, and other conditions. The FDA's Orange Book lists numerous approved Abbreviated New Drug Applications (ANDAs) for sertraline, indicating a competitive generic market. Notably, the patent for Zoloft, the brand-name version of sertraline, expired in 2006, facilitating the entry of generic versions. Given that 60.3% of India's sertraline exports are destined for the U.S., the presence of 218 active Indian exporters underscores the significance of the U.S. market for Indian manufacturers.

2EU & UK Regulatory Framework

In the European Union, sertraline is authorized for similar indications as in the U.S. The European Medicines Agency (EMA) conducted an Article 30 referral for Zoloft, resulting in a harmonized decision across member states in March 2009. Manufacturers exporting to the EU must comply with Good Manufacturing Practice (GMP) standards as outlined in EU Directive 2003/94/EC. The United Kingdom, post-Brexit, continues to align closely with EU regulations through the Medicines and Healthcare products Regulatory Agency (MHRA). Given that Belgium, Malta, and Finland collectively account for 21.4% of India's sertraline exports, adherence to these regulatory frameworks is crucial for market access.

3WHO Essential Medicines & Global Standards

Sertraline is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in global health. The 22nd edition of this list, updated in September 2021, features sertraline for the treatment of depressive disorders. Compliance with international pharmacopoeia standards, such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), is essential for manufacturers to ensure product quality and facilitate international trade.

4India Regulatory Classification

In India, sertraline is classified under Schedule H of the Drugs and Cosmetics Act, requiring a prescription for dispensing. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, sertraline is not listed under the Drug Price Control Order (DPCO), allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure compliance with national regulations and international commitments.

5Patent & Exclusivity Status

The primary patent for sertraline expired in 2006, leading to a robust generic market. Subsequent patents, such as US Patent No. 5,248,699 granted in September 1993, have also expired, further facilitating generic competition. This competitive landscape is reflected in the substantial number of Indian exporters and the significant export volumes to various international markets.

6Recent Industry Developments

In June 2025, the NPPA conducted a review of antidepressant pricing, including sertraline, to assess market dynamics and ensure affordability. Although no immediate price controls were implemented, the review signaled potential future regulatory actions.

In September 2025, the EMA initiated a Periodic Safety Update Report (PSUR) single assessment for sertraline, emphasizing the importance of ongoing pharmacovigilance in the EU market.

In December 2025, the WHO updated its Model List of Essential Medicines, reaffirming the inclusion of sertraline and highlighting its continued relevance in global mental health treatment protocols.

In February 2026, the CDSCO issued revised guidelines for the export of pharmaceuticals, including sertraline, to streamline the NOC process and enhance compliance with international standards.

In March 2026, the FDA approved a new generic version of sertraline, further intensifying competition in the U.S. market and potentially impacting export dynamics for Indian manufacturers.

These developments underscore the dynamic regulatory environment surrounding sertraline, necessitating continuous monitoring and compliance by stakeholders in the pharmaceutical export sector.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Sertraline

Retail & reference prices across 9 markets vs. India FOB export price of $2.15/unit

Global Price Benchmark for Sertraline across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.10	USD	According to the FDA's Orange Book, sertraline is available as a generic medication, contributing to its low cost.
United Kingdom	$0.07	GBP	The NHS Drug Tariff lists sertraline as a generic medication, resulting in affordable pricing.
Germany	$0.09	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) includes sertraline in its list of reimbursable medications, ensuring competitive pricing.
Australia	$0.11

Supply Chain Risk Assessment — Sertraline

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry heavily relies on China for key starting materials (KSMs) and active pharmaceutical ingredients (APIs). This dependency poses a significant risk, as any disruption in the supply chain from China can impact the production of essential drugs like Sertraline. Recent geopolitical tensions and trade restrictions have further highlighted the vulnerabilities associated with this reliance.

In response to these challenges, the Indian government has implemented the Production Linked Incentive (PLI) scheme to boost domestic manufacturing of critical APIs and KSMs. However, the effectiveness of this initiative in reducing dependency on Chinese imports remains to be fully realized. The ongoing efforts to strengthen domestic production are crucial for ensuring a stable supply chain for Sertraline and other pharmaceuticals.

2Supplier Concentration & Single-Source Risk

The export market for Sertraline from India is highly concentrated, with the top five exporters accounting for 88.8% of total exports. CIPLA LIMITED alone holds a 55.5% share, exporting $311.1 million worth of Sertraline. This high level of concentration increases the risk of supply disruptions, as any operational issues within these key companies can significantly impact global supply.

While the PLI scheme aims to diversify and strengthen the pharmaceutical manufacturing base, its impact on reducing supplier concentration in the Sertraline market is yet to be observed. Encouraging broader participation from smaller manufacturers could mitigate single-source risks and enhance supply chain resilience.

Access Complete Sertraline Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 5,183 transactions across 88 markets.

Request Demo View Pricing

Frequently Asked Questions — Sertraline Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top sertraline exporters from India?

The leading sertraline exporters from India are CIPLA LIMITED, AUROBINDO PHARMA LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED, and 12 others. CIPLA LIMITED leads with 55.5% market share ($311.1M). The top 5 suppliers together control 88.8% of total export value.

What is the total export value of sertraline from India?

The total export value of sertraline from India is $560.5M, recorded across 5,183 shipments from 218 active exporters to 88 countries. The average shipment value is $108.1K.

Which countries import sertraline from India?

India exports sertraline to 88 countries. The top importing countries are UNITED STATES (60.3%), BELGIUM (10.4%), MALTA (6.4%), FINLAND (4.6%), JAPAN (4.5%), which together account for 86.1% of total export value.

What is the HS code for sertraline exports from India?

The primary HS code for sertraline exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Sertraline

Sertraline

Top Sertraline Exporters from India

Top Countries Importing Sertraline from India

Who Supplies Sertraline to India?

Quick Facts

Related CNS & Psychiatric

Related Analysis

Need Details?

Regulatory Landscape — Sertraline

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Sertraline

Supply Chain Risk Assessment — Sertraline

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Sertraline Trade Intelligence

Frequently Asked Questions — Sertraline Exports from India

Who are the top sertraline exporters from India?

What is the total export value of sertraline from India?

Which countries import sertraline from India?

What is the HS code for sertraline exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of sertraline exports from India?

Which ports handle sertraline exports from India?

Why is India a leading exporter of sertraline?

What certifications do Indian sertraline exporters need?

How many buyers import sertraline from India?

What is the market share of the top sertraline exporter from India?

Analysis Methodology